Akanda (NASDAQ:AKAN) Rating Lowered to “Strong Sell” at Wall Street Zen

Akanda (NASDAQ:AKAN) was downgraded by equities research analysts at Wall Street Zen from a “sell” rating to a “strong sell” rating in a research report issued on Saturday.

Separately, Weiss Ratings restated a “sell (e+)” rating on shares of Akanda in a research note on Thursday, August 13th. One equities research analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, Akanda presently has an average rating of “Sell”.

Akanda Stock Performance

NASDAQ AKAN opened at $3.89 on Friday. Akanda has a 12 month low of $2.30 and a 12 month high of $209.02. The company’s 50 day moving average is $8.20 and its two-hundred day moving average is $10.14.

Akanda (NASDAQ:AKAN) last issued its quarterly earnings results on Tuesday, June 9th. The company reported ($317.90) earnings per share for the quarter.

About Akanda

Akanda Corp., through its subsidiaries, engages in the cultivation, manufacture, and distribution of cannabis products to patients worldwide. It offers medicinal-grade cannabis and cannabis based medical and wellness products. The company was incorporated in 2021 and is headquartered in New Romney, the United Kingdom.